ArticleJournal of hepatocellular carcinoma2026
NUP205 Stabilized YAP1 Protein to Stimulate Growth of Hepatocellular Carcinoma Cells in vitro and in vivo.
Article in Journal of hepatocellular carcinoma, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: Targeted therapy for hepatocellular carcinoma (HCC) is limited by drug resistance and other constraints, leaving treatments sub-optimal and making identification of new target genes urgent. Nuclear pore protein 205 (NUP205) is highly expressed in HCC and associated with poor prognosis but mechanisms of action remain unclear. The current study investigated functions of NUP205 in HCC. Methods: Bioinformatics analyses of NUP205 expression in HCC samples from The Cancer Genome Atlas, Gene Expression Omnibus and Kaplan-Meier databases were conducted. Proliferation and apoptosis were measured in HCC LM3 and SK-Hep1 cells with NUP205 knockdown and overexpression and growth of HCC xenografts in a nude mouse model. The stability of Yes-associated protein (YAP1) mRNA and protein in cells with NUP205 knockdown and overexpression was assessed. Results: NUP205 was overexpressed in HCC tissues and expression correlated with pathological grade and prognosis. NUP205 knockdown in vitro inhibited cell proliferation 2-3-fold, induced apoptosis 4-5-fold and suppressed in vivo tumor growth by 40%. Opposing effects were found for NUP205 overexpression. NUP205 acted via the ubiquitin-proteasome pathway to stabilize YAP1 protein. Conclusion: NUP205 stabilizes YAP1 and may be considered to act as an HCC oncogene. The NUP205-YAP1 axis may be a therapeutic target.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.